These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38588920)

  • 1. Re-irradiation for recurrent intracranial meningiomas: Analysis of clinical outcomes and prognostic factors.
    Desideri I; Morelli I; Banini M; Greto D; Visani L; Nozzoli F; Caini S; Della Puppa A; Livi L; Perini Z; Zivelonghi E; Bulgarelli G; Pinzi V; Navarria P; Clerici E; Scorsetti M; Ascolese AM; Osti MF; Anselmo P; Amelio D; Minniti G; Scartoni D
    Radiother Oncol; 2024 Jun; 195():110271. PubMed ID: 38588920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma.
    El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
    Radiat Oncol; 2018 May; 13(1):86. PubMed ID: 29739417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiologic Response and Disease Control of Recurrent Intracranial Meningiomas Treated With Reirradiation.
    Lin AJ; Hui C; Dahiya S; Lu HC; Kim AH; Campian JL; Tsien C; Zipfel GJ; Rich KM; Chicoine M; Huang J
    Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):194-203. PubMed ID: 29970312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.
    Rogers L; Zhang P; Vogelbaum MA; Perry A; Ashby LS; Modi JM; Alleman AM; Galvin J; Brachman D; Jenrette JM; De Groot J; Bovi JA; Werner-Wasik M; Knisely JPS; Mehta MP
    J Neurosurg; 2018 Jul; 129(1):35-47. PubMed ID: 28984517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting?
    Gupta T; Maitre M; Maitre P; Goda JS; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Epari S; Sahay A; Patil V; Jalali R
    Clin Transl Oncol; 2021 Jul; 23(7):1358-1367. PubMed ID: 33528810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of salvage surgery with or without reirradiation for skull base meningiomas recurring after prior radiotherapy.
    Rubino F; Schur S; McGovern SL; Kamiya-Matsuoka C; DeMonte F; Raza SM
    J Neurosurg; 2023 Sep; 139(3):798-809. PubMed ID: 36738459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
    Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
    Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large volume re-irradiation for recurrent meningioma with pulsed reduced dose rate radiotherapy.
    Witt JS; Musunuru HB; Bayliss RA; Howard SP
    J Neurooncol; 2019 Jan; 141(1):103-109. PubMed ID: 30392090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.
    Keric N; Kalasauskas D; Freyschlag CF; Gempt J; Misch M; Poplawski A; Lange N; Ayyad A; Thomé C; Vajkoczy P; Meyer B; Ringel F
    J Neurooncol; 2020 Jan; 146(2):347-355. PubMed ID: 31900826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic radiosurgery of World Health Organization grade II and III intracranial meningiomas: treatment results on the basis of a 22-year experience.
    Pollock BE; Stafford SL; Link MJ; Garces YI; Foote RL
    Cancer; 2012 Feb; 118(4):1048-54. PubMed ID: 21773968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.
    Lubgan D; Rutzner S; Lambrecht U; Rössler K; Buchfelder M; Eyüpoglu I; Fietkau R; Semrau S
    J Neurooncol; 2017 Sep; 134(2):407-416. PubMed ID: 28667597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
    Zhu H; Bi WL; Aizer A; Hua L; Tian M; Den J; Tang H; Chen H; Wang Y; Mao Y; Dunn IF; Xie Q; Gong Y
    Cancer Med; 2019 Jan; 8(1):13-20. PubMed ID: 30680963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
    Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
    Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic radiosurgery for WHO grade I posterior fossa meningiomas: long-term outcomes with volumetric evaluation.
    Patibandla MR; Lee CC; Tata A; Addagada GC; Sheehan JP
    J Neurosurg; 2018 Nov; 129(5):1249-1259. PubMed ID: 29303453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
    Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic radiosurgery versus stereotactic radiotherapy in the management of intracranial meningiomas: a systematic review and meta-analysis.
    Fatima N; Meola A; Pollom EL; Soltys SG; Chang SD
    Neurosurg Focus; 2019 Jun; 46(6):E2. PubMed ID: 31153149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma Knife radiosurgery for intracranial benign meningiomas: follow-up outcome in 130 patients.
    Ge Y; Liu D; Zhang Z; Li Y; Lin Y; Wang G; Zong Y; Liu E
    Neurosurg Focus; 2019 Jun; 46(6):E7. PubMed ID: 31153153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gross Tumor and Intracranial Control Benefits with Fractionated Radiotherapy Compared with Stereotactic Radiosurgery for Patients with WHO Grade 2 Meningioma.
    Gravbrot N; Rock CB; Weil CR; Rock CB; Burt LM; DeCesaris CM; Jensen RL; Shrieve DC; Cannon DM
    World Neurosurg; 2024 Aug; 188():e259-e266. PubMed ID: 38777319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas.
    Brachman DG; Youssef E; Dardis CJ; Sanai N; Zabramski JM; Smith KA; Little AS; Shetter AG; Thomas T; McBride HL; Sorensen S; Spetzler RF; Nakaji P
    J Neurosurg; 2019 Dec; 131(6):1819-1828. PubMed ID: 30579269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.